Non-HDL Cholesterol Blood Test: Normal Ranges, Causes & What Your Results Mean

What Is Non-HDL Cholesterol?

Non-HDL cholesterol is a calculated value that represents the total amount of "bad" cholesterol circulating in your blood. It is derived by subtracting your HDL (high-density lipoprotein) cholesterol, often called "good" cholesterol, from your total cholesterol. The resulting figure captures all the atherogenic (artery-clogging) lipoproteins in a single number: LDL cholesterol, VLDL cholesterol, IDL cholesterol, and lipoprotein(a).

Non-HDL cholesterol has gained increasing prominence in UK clinical practice and is now recommended by NICE as the primary lipid target for cardiovascular risk assessment and statin therapy monitoring. The reason is straightforward: non-HDL cholesterol provides a more complete picture of atherogenic risk than LDL cholesterol alone. LDL testing can miss important contributions from remnant cholesterol particles (VLDL and IDL), which are particularly relevant in patients with diabetes, metabolic syndrome, or high triglycerides.

The formula is simple:

Non-HDL Cholesterol = Total Cholesterol − HDL Cholesterol

One practical advantage of non-HDL cholesterol is that it can be accurately calculated from a non-fasting blood sample, whereas LDL cholesterol calculations (using the Friedewald equation) become unreliable when triglycerides are elevated. This makes non-HDL cholesterol a more strong and convenient measurement for routine clinical use.

Why Is Non-HDL Cholesterol Tested?

Non-HDL cholesterol is measured as part of a standard lipid profile. Key clinical indications include:

• Cardiovascular risk assessment: NICE Clinical Guideline CG181 recommends using non-HDL cholesterol alongside QRISK3 to estimate 10-year cardiovascular risk in adults aged 40–84.
• NHS Health Check: All adults in England aged 40–74 are invited for an NHS Health Check every five years, which includes a lipid profile with non-HDL cholesterol.
• Statin therapy monitoring: NICE recommends checking non-HDL cholesterol three months after starting a statin, with the target of achieving a 40% or greater reduction from baseline.
• Familial hypercholesterolaemia screening: Significantly elevated non-HDL cholesterol (above 5.0 mmol/L) raises suspicion for FH, which affects approximately 1 in 250 people in the UK.
• Diabetes management: People with type 2 diabetes have an elevated cardiovascular risk and benefit from aggressive lipid management. Non-HDL cholesterol is more accurate than LDL in this population because triglycerides are often raised.
• Metabolic syndrome: The combination of central obesity, insulin resistance, hypertension, and dyslipidaemia benefits from non-HDL cholesterol monitoring as it captures the full atherogenic lipoprotein burden.
• After a cardiovascular event: Patients who have had a heart attack or stroke require intensive lipid monitoring to ensure secondary prevention targets are met.

Normal Ranges

Non-HDL cholesterol is measured in millimoles per litre (mmol/L) in the UK. The following table shows the reference ranges and targets used in clinical practice:

Category	Non-HDL Cholesterol (mmol/L)	Interpretation
Ideal (general population)	< 4.0 mmol/L	Desirable level for healthy adults
Borderline elevated	4.0–4.9 mmol/L	Above optimal; lifestyle modification recommended
Elevated	5.0–5.9 mmol/L	Significantly raised; QRISK3 assessment and possible statin therapy
Very high	≥ 6.0 mmol/L	Consider familial hypercholesterolaemia; specialist referral may be needed
NICE statin target	40% reduction from baseline	Target for patients initiated on statin therapy
High-risk patients (secondary prevention)	< 2.5 mmol/L	Stricter target for those with established CVD

NICE does not specify a single absolute non-HDL cholesterol target for primary prevention. Instead, the focus is on achieving a 40% or greater reduction from the pre-treatment baseline. For secondary prevention (patients with existing cardiovascular disease), many specialists aim for non-HDL cholesterol below 2.5 mmol/L, and some European guidelines target below 2.2 mmol/L in very high-risk patients.

What Do High Non-HDL Cholesterol Levels Mean?

Elevated non-HDL cholesterol increases the risk of atherosclerosis - the progressive build-up of fatty plaques in arterial walls that can lead to heart attack, stroke, and peripheral arterial disease. Causes of high non-HDL cholesterol include:

• Diet high in saturated fat: Fatty meats, full-fat dairy, butter, cheese, pastries, cakes, and biscuits are major dietary contributors to raised cholesterol in the UK.
• Familial hypercholesterolaemia (FH): A genetic condition affecting approximately 1 in 250 people. It causes very high LDL and non-HDL cholesterol from birth, leading to premature cardiovascular disease if untreated.
• Obesity and overweight: Excess body fat, particularly visceral (abdominal) fat, is strongly associated with raised non-HDL cholesterol, high triglycerides, and low HDL.
• Type 2 diabetes: Insulin resistance drives hepatic overproduction of VLDL, raising non-HDL cholesterol. The "diabetic dyslipidaemia" pattern (high triglycerides, low HDL, small dense LDL) is common.
• Hypothyroidism: An underactive thyroid reduces LDL receptor activity, causing cholesterol to accumulate in the blood. Lipid levels often normalise with levothyroxine treatment.
• Nephrotic syndrome: Heavy proteinuria stimulates hepatic lipoprotein synthesis, causing marked hypercholesterolaemia.
• Cholestatic liver disease: Conditions causing bile duct obstruction (primary biliary cholangitis, gallstones) can dramatically raise cholesterol.
• Medications: Corticosteroids, some antipsychotics, certain antiretroviral drugs, and high-dose thiazide diuretics can raise non-HDL cholesterol.

What Do Low Non-HDL Cholesterol Levels Mean?

Low non-HDL cholesterol is generally associated with lower cardiovascular risk, but very low values may occasionally warrant investigation:

• Effective statin therapy: Statins, ezetimibe, and PCSK9 inhibitors can substantially lower non-HDL cholesterol. Achieving very low levels (below 1.8 mmol/L) on treatment is considered beneficial in high-risk patients.
• Naturally low cholesterol: Some individuals have genetically low cholesterol levels. This is typically benign and associated with reduced cardiovascular risk.
• Hyperthyroidism: An overactive thyroid increases LDL receptor expression, accelerating cholesterol clearance and lowering non-HDL.
• Malnutrition or malabsorption: Severe caloric restriction, eating disorders, coeliac disease, or other malabsorptive conditions can reduce lipid levels.
• Liver failure: Advanced hepatic disease impairs lipoprotein production, leading to low cholesterol. This is a marker of poor prognosis rather than cardiovascular benefit.
• Chronic inflammatory conditions: Severe systemic illness, sepsis, and advanced cancer can cause low cholesterol through cytokine-mediated changes in hepatic lipid metabolism.
• Abetalipoproteinaemia: A rare genetic condition causing extremely low or absent LDL. Patients develop fat malabsorption, neurological problems, and retinal disease.

How to Improve Your Non-HDL Cholesterol Levels

Dietary Changes (First-Line Approach)

• Reduce saturated fat: The NHS recommends no more than 20g of saturated fat per day for women and 30g for men. Swap butter for olive oil or rapeseed oil, choose lean meats, and limit pastries, biscuits, and processed foods.
• Increase soluble fibre: Oats, barley, beans, lentils, chickpeas, and fruits such as apples and oranges contain beta-glucan and pectin, which bind cholesterol in the gut and reduce its absorption. Aim for at least 30g of total fibre daily.
• Eat plant sterols and stanols: These naturally occurring compounds (found in fortified spreads, yoghurts, and supplements) can reduce LDL cholesterol by 7–10% when consumed at 1.5–2.4g per day.
• Increase omega-3 fatty acids: Oily fish (salmon, mackerel, sardines, herring) eaten at least twice a week can lower triglycerides and improve the overall lipid profile.
• Eat more nuts: A handful (30g) of unsalted almonds, walnuts, or hazelnuts daily has been shown to modestly lower LDL and non-HDL cholesterol.
• Choose wholegrain carbohydrates: Replace white bread, rice, and pasta with wholegrain alternatives.

Lifestyle Modifications

• Regular physical activity: At least 150 minutes of moderate-intensity aerobic exercise per week (brisk walking, cycling, swimming). Exercise raises HDL and may modestly lower LDL.
• Maintain a healthy weight: Losing 5–10% of body weight if overweight can significantly improve lipid levels.
• Stop smoking: Smoking lowers HDL cholesterol and damages arterial walls, accelerating atherosclerosis. Quitting improves the lipid profile within weeks.
• Moderate alcohol consumption: Limit to 14 units per week or less, spread over three or more days.

Medical Treatment

• Statins: The cornerstone of lipid-lowering therapy. Atorvastatin 20mg is recommended by NICE for primary prevention, with dose titration to achieve a 40% non-HDL cholesterol reduction.
• Ezetimibe: Added to statin therapy if targets are not met. Inhibits cholesterol absorption in the small intestine.
• PCSK9 inhibitors: Evolocumab and alirocumab are injectable therapies for patients with FH or very high cardiovascular risk who do not achieve targets on maximal statin and ezetimibe therapy.
• Bempedoic acid: A newer oral option for patients who cannot tolerate statins.
• Inclisiran: A twice-yearly injection (siRNA therapy) that lowers LDL cholesterol. Now available through the NHS for eligible patients.

When Should You Get Tested?

You should have your non-HDL cholesterol measured if:

• You are aged 40 or over and due for an NHS Health Check.
• You have a family history of premature heart disease or stroke.
• You have been diagnosed with or are at risk of familial hypercholesterolaemia.
• You have type 2 diabetes, hypertension, or metabolic syndrome.
• You are currently taking a statin and need monitoring (three months after initiation, then annually).
• You smoke, are overweight, or have a sedentary lifestyle.
• You have had a heart attack, stroke, or peripheral vascular disease.
• You want a comprehensive understanding of your cardiovascular risk.

Non-HDL cholesterol can be measured from a non-fasting blood sample, making it more convenient than some other lipid measurements.

Which Lola Health Tests Include Non-HDL Cholesterol?

Non-HDL cholesterol is a core component of cardiovascular health assessment. Lola Health includes it in the following panels:

• Peak Insights - our most detailed test, featuring a full lipid profile with non-HDL cholesterol, LDL, HDL, triglycerides, total cholesterol, and Lp(a).
• Vital Check — a thorough wellness panel covering cardiovascular, metabolic, and hormonal health.
• Core Health — an essential health check that includes key cardiovascular lipid markers.

All Lola Health tests use venous blood draws for clinical-grade accuracy. Your results are reviewed by qualified healthcare professionals who provide personalised recommendations for managing your cardiovascular risk.